Articles tagged with: Ovarian

New Group Leaders at BCI

Posted in General News Published by Reza Roozitalab 16 October 2017

New and familiar faces at Barts Cancer Institute

New Group Leaders at BCI

Congratulations to academic staff members Dr Jessica Okosun & Kevin Rouault-Pierre from our Centre for Haematology Oncology and Dr Oliver Pearce from the Centre for Cancer & Inflammation! 

Find out more about the research that our new group leaders will carry out...

Chemotherapy before surgery could boost ovarian cancer response to immunotherapy

Posted in In the Press, Publications Published by Zoe Leech 15 June 2016

New study published in Clinical Cancer Research by Prof Balkwill

Chemotherapy before surgery could boost ovarian cancer response to immunotherapy

Professor Fran Balkwill has published a study on ovarian cancer responses to treatment, which could mean hope for patients whose cancer has already spread.

The findings suggest that giving chemotherapy before surgery could improve tumour responses to immunotherapy given afterwards, by making the cancer cells more susceptible to immune attack by the immune system...

Tackling ovarian cancer on two fronts

Posted in Grants & Awards Published by Zoe Leech 28 September 2015

Armed with viruses and the immune system

Tackling ovarian cancer on two fronts

Dr Michelle Lockley in our Centre for Molecular Oncology now has a Cancer Research UK Clinician Scientist Fellowship to continue working on oncolytic viruses for ovarian cancer.

High grade serous cancer (HGSC) is the most common subtype of ovarian cancer. Chemotherapy is usually successful at first, but > 70% of patients develop resistance...

Making anti-cancer viruses safer for ovarian cancer patients

Posted in Publications Published by Zoe Leech 24 June 2015

Making anti-cancer viruses safer for ovarian cancer patients

Dr Michelle Lockley's group has published a new study in Cancer Research showing exciting progress in the use of viruses to treat ovarian cancer.

They've found a way to potentially reduce inflammation by targeting an integrin on macrophage cells, which oncolytic viruses can bind to...

QMUL Experts: Professor Fran Balkwill on Ovarian Cancer

Posted in Engagement Published by Zoe Leech 12 September 2014

QMUL Experts: Professor Fran Balkwill on Ovarian Cancer

September 2014 is National Ovarian Cancer Awareness month in the USA. Our Professor of Cancer Biology, Fran Balkwill, leads the Centre for Cancer and Inflammation. Fran studies Ovarian Cancer with a focus on high grade serous and clear cell subtypes. Watch her QMUL Experts video...

Investigating the ovarian cancer microenvironment

Posted in Grants & Awards Published by Marianne Baker 25 April 2013

Investigating the ovarian cancer microenvironment

Congratulations to Professor Frances Balkwill, who has successfully secured 5 years' funding from Cancer Research UK to study the ovarian cancer microenvironment at the Centre for Cancer and Inflammation - confirmed on April 24th...

CANBUILD - Engineering 3D Human Tumours

Posted in Grants & Awards Published by Marianne Baker 22 April 2013

CANBUILD - Engineering 3D Human Tumours

The European Research Council (ERC) has awarded researchers at Barts Cancer Institute, Queen Mary University of London, a £2.43million grant for a project that aims to revolutionise the field of cancer cell research: using bioengineering techniques to grow the first complex 3D human tumour in the laboratory...

This site uses cookies in order to function properly. By continuing to browse, you agree that we can save them on your device. Privacy Policy.